All News
Windfarm profits should be used to screen Scots for rare diseases, says scientist
Geneticist who discovered hotspots of illnesses in Scottish islands calls for redirection of community benefit fundsA leading geneticist has called for the profits from windfarms to be used for the ma
Read MoreSTAT+: Biotech is in a dark place
Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index is down 19% in the same time period.
Read MoreRepublican States Claim Zero Abortions. A Red-State Doctor Calls That ‘Ludicrous.’
In several red states, officials say few or no abortions happened in 2023, raising alarm among researchers about the politicization of vital statistics.
Read MoreTop California Democrats Clash Over How To Rein In Drug Industry Middlemen
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries known as pharmacy benefit managers.
Read MoreMontana Looks To Regulate Prior Authorization as Patients, Providers Decry Obstacles to Care
Patients and providers say health insurers’ preapproval requirements lead to delays and denials of needed medical treatments. Insurers argue that prior authorization keeps costs down.
Read MoreYoung researchers mobilize to protest Trump administration’s science policies
Stunned by attacks on the scientific research system, early career scientists plan a D.C. demonstration and a national ‘Stand Up for Science’ event.
Read MoreAs officials prepare for WHO-led flu vaccine meeting, many wonder: Will the U.S. show?
Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's unclear if the U.S. will show.
Read MoreOpinion: How to close America’s life expectancy gap
The U.S. ranks 29th in life expectancy at birth among peer nations in the OECD. Changing that goes well beyond the health care system.
Read MoreOpinion: The FDA must remove an unnecessary barrier to the use of clozapine for treatment-resistant schizophrenia
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health care in this country.
Read More